help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yousef, G. M.
Right arrow Articles by Diamandis, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yousef, G. M.
Right arrow Articles by Diamandis, E. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Endocrine Reviews 22 (2): 184-204
Copyright © 2001 by The Endocrine Society

The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease1

George M. Yousef and Eleftherios P. Diamandis

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5; and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada M5G 1L5

The human tissue kallikrein gene family was, until recently, thought to consist of only three genes. Two of these human kallikreins, prostate-specific antigen and human glandular kallikrein 2, are currently used as valuable biomarkers of prostatic carcinoma. More recently, new kallikrein-like genes have been discovered. It is now clear that the human tissue kallikrein gene family contains at least 15 genes. All genes share important similarities, including mapping at the same chromosomal locus (19q13.4), significant homology at both the nucleotide and protein level, and similar genomic organization. All genes encode for putative serine proteases and most of them are regulated by steroid hormones. Recent data suggest that at least a few of these kallikrein genes are connected to malignancy. In this review, we summarize the recently accumulated knowledge on the human tissue kallikrein gene family, including gene and protein structure, predicted enzymatic activities, tissue expression, hormonal regulation, and alternative splicing. We further describe the reported associations of the human kallikreins with various human diseases and identify future avenues for research.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. S. Tykodi, N. Fujii, N. Vigneron, S. M. Lu, J. K. Mito, M. X. Miranda, J. Chou, L. N. Voong, J. A. Thompson, B. M. Sandmaier, et al.
C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients
Clin. Cancer Res., August 15, 2008; 14(16): 5260 - 5269.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
H.-X. Li, B.-Y. Hwang, G. Laxmikanthan, S. I. Blaber, M. Blaber, P. A. Golubkov, P. Ren, B. L. Iverson, and G. Georgiou
Substrate specificity of human kallikreins 1 and 6 determined by phage display
Protein Sci., April 1, 2008; 17(4): 664 - 672.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Emami and E. P. Diamandis
Human Kallikrein-related Peptidase 14 (KLK14) Is a New Activator Component of the KLK Proteolytic Cascade: POSSIBLE FUNCTION IN SEMINAL PLASMA AND SKIN
J. Biol. Chem., February 8, 2008; 283(6): 3031 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Yoon, G. Laxmikanthan, J. Lee, S. I. Blaber, A. Rodriguez, J. M. Kogot, I. A. Scarisbrick, and M. Blaber
Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases
J. Biol. Chem., November 2, 2007; 282(44): 31852 - 31864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. W. McIntosh, Y. Liu, C. Drescher, N. Urban, and E. P. Diamandis
Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma
Clin. Cancer Res., August 1, 2007; 13(15): 4422 - 4428.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. L.V. Shaw and E. P. Diamandis
Distribution of 15 Human Kallikreins in Tissues and Biological Fluids
Clin. Chem., August 1, 2007; 53(8): 1423 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Borgono, I. P. Michael, J. L. V. Shaw, L.-Y. Luo, M. C. Ghosh, A. Soosaipillai, L. Grass, D. Katsaros, and E. P. Diamandis
Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14
J. Biol. Chem., January 26, 2007; 282(4): 2405 - 2422.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S C Fernando, J S Buck, M D Ashworth, J W Ross, R D Geisert, and U DeSilva
Porcine endometrial and conceptus tissue kallikrein 1, 4, 11, and 14 gene expression.
Reproduction, December 1, 2006; 132(6): 939 - 947.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Oikonomopoulou, K. K. Hansen, M. Saifeddine, I. Tea, M. Blaber, S. I. Blaber, I. Scarisbrick, P. Andrade-Gordon, G. S. Cottrell, N. W. Bunnett, et al.
Proteinase-activated Receptors, Targets for Kallikrein Signaling
J. Biol. Chem., October 27, 2006; 281(43): 32095 - 32112.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. J. C. Shan, A. Scorilas, D. Katsaros, I. Rigault de la Longrais, M. Massobrio, and E. P. Diamandis
Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols
Clin. Chem., October 1, 2006; 52(10): 1879 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. H. Slagter, L. J.G. Gooren, A. Scorilas, C. D. Petraki, and E. P. Diamandis
Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals
J. Histochem. Cytochem., August 1, 2006; 54(8): 905 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. H. Slagter, A. Scorilas, L. J.G. Gooren, W. de Ronde, A. Soosaipillai, E. J. Giltay, M. Paliouras, and E. P. Diamandis
Effect of Testosterone Administration on Serum and Urine Kallikrein Concentrations in Female-to-Male Transsexuals
Clin. Chem., August 1, 2006; 52(8): 1546 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. H. Slagter, L. J.G. Gooren, W. de Ronde, A. Soosaipillai, A. Scorilas, E. J. Giltay, M. Paliouras, and E. P. Diamandis
Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens
Clin. Chem., July 1, 2006; 52(7): 1356 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. Holzscheiter, J. C. Biermann, M. Kotzsch, P. Prezas, J. Farthmann, G. Baretton, T. Luther, V. C.G. Tjan-Heijnen, M. Talieri, M. Schmitt, et al.
Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer
Clin. Chem., June 1, 2006; 52(6): 1070 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. P. Michael, G. Pampalakis, S. D. Mikolajczyk, J. Malm, G. Sotiropoulou, and E. P. Diamandis
Human Tissue Kallikrein 5 Is a Member of a Proteolytic Cascade Pathway Involved in Seminal Clot Liquefaction and Potentially in Prostate Cancer Progression
J. Biol. Chem., May 5, 2006; 281(18): 12743 - 12750.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
S. Nettikadan, K. Radke, J. Johnson, J. Xu, M. Lynch, C. Mosher, and E. Henderson
Detection and Quantification of Protein Biomarkers from Fewer than 10 Cells
Mol. Cell. Proteomics, May 1, 2006; 5(5): 895 - 901.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Yao, M. R. Karabasil, N. Purwanti, X. Li, T. Akamatsu, N. Kanamori, and K. Hosoi
Tissue Kallikrein mK13 Is a Candidate Processing Enzyme for the Precursor of Interleukin-1beta in the Submandibular Gland of Mice
J. Biol. Chem., March 24, 2006; 281(12): 7968 - 7976.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M.R. Darling, L. Jackson-Boeters, T.D. Daley, and E.P. Diamandis
Human Kallikrein 6 Expression in Salivary Gland Tumors
J. Histochem. Cytochem., March 1, 2006; 54(3): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. A. Borgono, T. Kishi, A. Scorilas, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt, and E. P. Diamandis
Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer
Clin. Cancer Res., March 1, 2006; 12(5): 1487 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. F. Angelo, A. R. Lima, F. M. Alves, S. I. Blaber, I. A. Scarisbrick, M. Blaber, L. Juliano, and M. A. Juliano
Substrate Specificity of Human Kallikrein 6: SALT AND GLYCOSAMINOGLYCAN ACTIVATION EFFECTS
J. Biol. Chem., February 10, 2006; 281(6): 3116 - 3126.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L.-Y. Luo, S. J.C. Shan, M. B. Elliott, A. Soosaipillai, and E. P. Diamandis
Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma
Clin. Cancer Res., February 1, 2006; 12(3): 742 - 750.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Tang, C. L. Yu, S. R. Williams, E. Springman, D. Jeffery, P. A. Sprengeler, A. Estevez, J. Sampang, W. Shrader, J. Spencer, et al.
Expression, Crystallization, and Three-dimensional Structure of the Catalytic Domain of Human Plasma Kallikrein
J. Biol. Chem., December 9, 2005; 280(49): 41077 - 41089.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
Y Dong, L T Bui, D M Odorico, O L Tan, S A Myers, H Samaratunga, R A Gardiner, and J A Clements
Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms
Endocr. Relat. Cancer, December 1, 2005; 12(4): 875 - 889.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Wang, E. M. John, and S. A. Ingles
Androgen Receptor and Prostate-Specific Antigen Gene Polymorphisms and Breast Cancer in African-American Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2990 - 2994.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Nagahara, K. Mimori, T. Utsunomiya, G. F. Barnard, M. Ohira, K. Hirakawa, and M. Mori
Clinicopathologic and Biological Significance of Kallikrein 6 Overexpression in Human Gastric Cancer
Clin. Cancer Res., October 1, 2005; 11(19): 6800 - 6806.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Iwai, N. Yasui, H. Naraba, N. Tago, H. Yamawaki, and H. Sumiya
Klk1 as One of the Genes Contributing to Hypertension in Dahl Salt-Sensitive Rat
Hypertension, May 1, 2005; 45(5): 947 - 953.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. P. Michael, G. Sotiropoulou, G. Pampalakis, A. Magklara, M. Ghosh, G. Wasney, and E. P. Diamandis
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
J. Biol. Chem., April 15, 2005; 280(15): 14628 - 14635.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ogawa, T. Utsunomiya, K. Mimori, F. Tanaka, H. Inoue, H. Nagahara, S. Murayama, and M. Mori
Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal Cancer
Clin. Cancer Res., April 15, 2005; 11(8): 2889 - 2893.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. S. Okerberg, J. Wu, B. Zhang, B. Samii, K. Blackford, D. T. Winn, K. R. Shreder, J. J. Burbaum, and M. P. Patricelli
High-resolution functional proteomics by active-site peptide profiling
PNAS, April 5, 2005; 102(14): 4996 - 5001.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A Del Rosso, O Distler, A F Milia, C Emanueli, L Ibba-Manneschi, S Guiducci, M L Conforti, S Generini, A Pignone, S Gay, et al.
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement
Ann Rheum Dis, March 1, 2005; 64(3): 382 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. P. Michael, L. Kurlender, N. Memari, G. M. Yousef, D. Du, L. Grass, C. Stephan, K. Jung, and E. P. Diamandis
Intron Retention: A Common Splicing Event within the Human Kallikrein Gene Family
Clin. Chem., March 1, 2005; 51(3): 506 - 515.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
V. Vaisanen, S. Eriksson, K. K. Ivaska, H. Lilja, M. Nurmi, and K. Pettersson
Development of Sensitive Immunoassays for Free and Total Human Glandular Kallikrein 2
Clin. Chem., September 1, 2004; 50(9): 1607 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Dupont, M. K. Tanwar, H. T. Thaler, M. Fleisher, N. Kauff, M. L. Hensley, P. Sabbatini, S. Anderson, C. Aghajanian, E. C. Holland, et al.
Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40
J. Clin. Oncol., August 15, 2004; 22(16): 3330 - 3339.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, R. C. Bast Jr., Y. Yu, J. Li, L. J. Sokoll, A. J. Rai, J. M. Rosenzweig, B. Cameron, Y. Y. Wang, X.-Y. Meng, et al.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Cancer Res., August 15, 2004; 64(16): 5882 - 5890.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
P S Hart, T C Hart, M D Michalec, O H Ryu, D Simmons, S Hong, and J T Wright
Mutation in kallikrein 4 causes autosomal recessive hypomaturation amelogenesis imperfecta
J. Med. Genet., July 1, 2004; 41(7): 545 - 549.
[Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. A. Borgono, I. P. Michael, and E. P. Diamandis
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
L. J. Spicer
Proteolytic Degradation of Insulin-Like Growth Factor Binding Proteins by Ovarian Follicles: A Control Mechanism for Selection of Dominant Follicles
Biol Reprod, May 1, 2004; 70(5): 1223 - 1230.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Shigemasa, L. Gu, H. Tanimoto, T. J. O'Brien, and K. Ohama
Human Kallikrein Gene 11 (KLK11) mRNA Overexpression Is Associated with Poor Prognosis in Patients with Epithelial Ovarian Cancer
Clin. Cancer Res., April 15, 2004; 10(8): 2766 - 2770.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
X. S. Puente and C. Lopez-Otin
A Genomic Analysis of Rat Proteases and Protease Inhibitors
Genome Res., April 1, 2004; 14(4): 609 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
E. P. Diamandis
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations
Mol. Cell. Proteomics, April 1, 2004; 3(4): 367 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Kishi, A. Soosaipillai, L. Grass, S. P. Little, E. M. Johnstone, and E. P. Diamandis
Development of an Immunofluorometric Assay and Quantification of Human Kallikrein 7 in Tissue Extracts and Biological Fluids
Clin. Chem., April 1, 2004; 50(4): 709 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
X. Xie, Z. Luo, K. M. Slawin, and D. M. Spencer
The EZC-Prostate Model: Noninvasive Prostate Imaging in Living Mice
Mol. Endocrinol., March 1, 2004; 18(3): 722 - 732.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Wang, J. Grunler, and M. S. Lewitt
Gender-Specific Pattern of Insulin-Like Growth Factor-Binding Protein-3 Protease Activity in Mouse Thyroid
Endocrinology, March 1, 2004; 145(3): 1137 - 1143.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Scorilas, C. A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt, and E. P. Diamandis
Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker
J. Clin. Oncol., February 15, 2004; 22(4): 678 - 685.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. A. Borgono, L. Grass, A. Soosaipillai, G. M. Yousef, C. D. Petraki, D. H. C. Howarth, S. Fracchioli, D. Katsaros, and E. P. Diamandis
Human Kallikrein 14: A New Potential Biomarker for Ovarian and Breast Cancer
Cancer Res., December 15, 2003; 63(24): 9032 - 9041.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. M. Yousef, A. Scorilas, D. Katsaros, S. Fracchioli, L. Iskander, C. Borgono, I. A. Rigault de la Longrais, M. Puopolo, M. Massobrio, and E. P. Diamandis
Prognostic Value of the Human Kallikrein Gene 15 Expression in Ovarian Cancer
J. Clin. Oncol., August 15, 2003; 21(16): 3119 - 3126.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W.-S. Cheng, V. Giandomenico, I. Pastan, and M. Essand
Characterization of the Androgen-Regulated Prostate-Specific T Cell Receptor {gamma}-Chain Alternate Reading Frame Protein (TARP) Promoter
Endocrinology, August 1, 2003; 144(8): 3433 - 3440.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Yousef, M.-E. Polymeris, L. Grass, A. Soosaipillai, P.-C. Chan, A. Scorilas, C. Borgono, N. Harbeck, B. Schmalfeldt, J. Dorn, et al.
Human Kallikrein 5: A Potential Novel Serum Biomarker for Breast and Ovarian Cancer
Cancer Res., July 15, 2003; 63(14): 3958 - 3965.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kishi, L. Grass, A. Soosaipillai, A. Scorilas, N. Harbeck, B. Schmalfeldt, J. Dorn, M. Mysliwiec, M. Schmitt, and E. P. Diamandis
Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma
Cancer Res., June 1, 2003; 63(11): 2771 - 2774.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Yousef, M.-E. Polymeris, G. M. Yacoub, A. Scorilas, A. Soosaipillai, C. Popalis, S. Fracchioli, D. Katsaros, and E. P. Diamandis
Parallel Overexpression of Seven Kallikrein Genes in Ovarian Cancer
Cancer Res., May 1, 2003; 63(9): 2223 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Hutchinson, L.-Y. Luo, G. M. Yousef, A. Soosaipillai, and E. P. Diamandis
Purification of Human Kallikrein 6 from Biological Fluids and Identification of its Complex with {alpha}1-Antichymotrypsin
Clin. Chem., May 1, 2003; 49(5): 746 - 751.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
C. D. Petraki, V. N. Karavana, and E. P. Diamandis
Human Kallikrein 13 Expression in Normal Tissues: An Immunohistochemical Study
J. Histochem. Cytochem., April 1, 2003; 51(4): 493 - 501.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. P. Diamandis, A. Scorilas, S. Fracchioli, M. van Gramberen, H. de Bruijn, A. Henrik, A. Soosaipillai, L. Grass, G. M. Yousef, U.-H. Stenman, et al.
Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma
J. Clin. Oncol., March 15, 2003; 21(6): 1035 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-Y. Luo, D. Katsaros, A. Scorilas, S. Fracchioli, R. Bellino, M. van Gramberen, H. de Bruijn, A. Henrik, U.-H. Stenman, M. Massobrio, et al.
The Serum Concentration of Human Kallikrein 10 Represents a Novel Biomarker for Ovarian Cancer Diagnosis and Prognosis
Cancer Res., February 15, 2003; 63(4): 807 - 811.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. P. Balk, Y.-J. Ko, and G. J. Bubley
Biology of Prostate-Specific Antigen
J. Clin. Oncol., January 15, 2003; 21(2): 383 - 391.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Kapadia, A. Chang, G. Sotiropoulou, G. M. Yousef, L. Grass, A. Soosaipillai, X. Xing, D. H.C. Howarth, and E. P. Diamandis
Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay
Clin. Chem., January 1, 2003; 49(1): 77 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Kishi, L. Grass, A. Soosaipillai, C. Shimizu-Okabe, and E. P. Diamandis
Human Kallikrein 8: Immunoassay Development and Identification in Tissue Extracts and Biological Fluids
Clin. Chem., January 1, 2003; 49(1): 87 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. MITSUI, A. OKUI, H. UEMURA, T. MIZUNO, T. YAMADA, Y. YAMAMURA, and N. YAMAGUCHI
Decreased Cerebrospinal Fluid Levels of Neurosin (KLK6), an Aging-Related Protease, as a Possible New Risk Factor for Alzheimer's Disease
Ann. N.Y. Acad. Sci., November 1, 2002; 977(1): 216 - 223.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
C. D. Petraki, V. N. Karavana, L.-Y. Luo, and E. P. Diamandis
Human Kallikrein 10 Expression in Normal Tissues by Immunohistochemistry
J. Histochem. Cytochem., September 1, 2002; 50(9): 1247 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. P. Diamandis and G. M. Yousef
Human Tissue Kallikreins: A Family of New Cancer Biomarkers
Clin. Chem., August 1, 2002; 48(8): 1198 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. V. Obiezu, A. Soosaipillai, K. Jung, C. Stephan, A. Scorilas, D. H. C. Howarth, and E. P. Diamandis
Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry
Clin. Chem., August 1, 2002; 48(8): 1232 - 1240.
[Abstract] [Full Text] [PDF]